Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Kyhl 2017 Peptides

From Bioblast
Publications in the MiPMap
Kyhl K, Lønborg J, Hartmann B, Kissow H, Poulsen SS, Ali HE, Kjær A, Dela F, Engstrøm T, Treiman M (2017) Lack of effect of prolonged treatment with liraglutide on cardiac remodeling in rats after acute myocardial infarction. Peptides 93:1-12.

» PMID: 28460895

Kyhl K, Loenborg J, Hartmann B, Kissow H, Poulsen SS, Ali HE, Kjaer A, Dela F, Engstroem T, Treiman M (2017) Peptides

Abstract: Following the acute phase of a myocardial infarction, a set of structural and functional changes evolves in the myocardium, collectively referred to as cardiac remodeling. This complex set of processes, including interstitial fibrosis, inflammation, myocyte hypertrophy and apoptosis may progress to heart failure. Analogs of the incretin hormone glucagon-like peptide 1 (GLP-1) have shown some promise as cardioprotective agents. We hypothesized that a long-acting GLP-1 analog liraglutide would ameliorate cardiac remodeling over the course of 4 weeks in a rat model of non-reperfused myocardial infarction. In 134 male Sprague Dawley rats myocardial infarctions were induced by ligation of the left anterior descending coronary artery. Rats were randomized to either subcutaneous injection of placebo or 0.3mg liraglutide once daily. Cardiac magnetic resonance imaging was performed after 4 weeks. Histology of the infarcted and remote non-infarcted myocardium, selected molecular remodeling markers and mitochondrial respiration in fibers of remote non-infarcted myocardium were analyzed. Left ventricular end diastolic volume increased in the infarcted hearts by 62% (from 0.58±0.03mL to 0.95±0.07mL, P<0.05) compared to sham operated hearts and left ventricle ejection fraction decreased by 37% (63±1%-40±3%, P<0.05). Increased interstitial fibrosis and phosphorylation of p38 Mitogen Activated Protein Kinase were observed in the non-infarct regions. Mitochondrial fatty acid oxidation was impaired. Liraglutide did not affect any of these alterations. Four-week treatment with liraglutide did not affect cardiac remodeling following a non-reperfused myocardial infarction, as assessed by cardiac magnetic resonance imaging, histological and molecular analysis and measurements of mitochondrial respiration.

Copyright © 2017 Elsevier Inc. All rights reserved. Keywords: Acute myocardial infarction, Cardiac magnetic resonance, Cardiac remodeling, GLP-1 receptor analog, Heart failure, Liraglutide Bioblast editor: Kandolf G O2k-Network Lab: DK Copenhagen Dela F, DK Copenhagen Larsen S

Labels: MiParea: Respiration  Pathology: Cardiovascular, Myopathy 

Organism: Rat  Tissue;cell: Heart  Preparation: Permeabilized tissue 

Regulation: ADP, Fatty acid  Coupling state: LEAK, OXPHOS  Pathway: F, N, S, NS, ROX  HRR: Oxygraph-2k